Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr: the ACTIVATE trial

http://cpep.rehab.med.ubc.ca/files/2013/04/UBC-tagline.png   Image result for university of ottawa logo

Principle Investigator (Vancouver Site):

Dr. Kristin Campbell

Principle Investigator (Ottawa Site):

Dr. Jennifer Brunet

Research Coordinator (Vancouver Site):

Aaliya Merali, MSc

Purpose:

The aim of the ACTIVATE trial is to evaluate the impact of a supervised aerobic exercise intervention on chemotherapy-related cognitive changes (CRCC) in women diagnosed with early stage breast cancer. Chemotherapy-related cognitive changes (CRCC) are reported by up to 75% of breast  cancer survivors during treatment and symptoms persist in 35% of survivors after treatment. Aerobic exercise is associated with improved quality of life in breast cancer survivors and holds promise as an intervention to prevent or mitigate CRCC.

Intervention:

The intervention involves 3X weekly supervised aerobic exercise training for 12-16 weeks. All programs are facilitated by staff who have experience working with cancer patients.

If you are a women who is receiving adjuvant chemotherapy and you are interested in participating, please contact Aaliya Merali at activate.trail@ubc.ca, or 604-827-1914 to gather more information and determine your eligibility for the trial.